Main navigation
You are here
- Home
Investor relations
Creating value for shareholders by making the most meaningful difference to patient health through great medicines
-
Latest news expand
Research & Development collapse
We focus our research on six disease areas where we believe our skills and experience can make the most difference.
-
Annual Report 2008 collapse
Latest presentation collapse
Financial results collapse
Third Quarter & Nine Months results 2009 announced Thursday, 29 October 2009.
Managing your shares collapse
Currency Guidance 2009 collapse
Not signed in
Page tools
Share price
- London
-
26.95 GBP - New York
-
44.82 USD - Stockholm
-
310.10 SEK
At 21-Nov-2009 09:00 GMT
Detailed share priceStock symbol - AZN
On LSE, NYSE and OMX
Introduction to AstraZeneca
Our responsibility
We continue to communicate openly on a range of issues, including:

Interactive stock charts
Share holding calculator
Share price look-up
Share price history